Refine your search
-
Authors
- Aroda, Vanita R [x]
-
Item types
-
Topics
- *Anti-Obesity Agents/ae [Adverse Effects]
- *Brain/de [Drug Effects]
- *Diabetes Mellitus/dt [Drug Therapy]
- *Glucagon-Like Peptide-1 Receptor/ag [Agonists]
- *Hypoglycemic Agents/tu [Therapeutic Use]
- *Liraglutide/ae [Adverse Effects]
- *Neurotoxicity Syndromes/ep [Epidemiology]
- *Obesity/dt [Drug Therapy]
- Adult
- Aged
- Anti-Obesity Agents/ad [Administration & Dosage]
- Brain/ph [Physiology]
- Clinical Trials, Phase II as Topic/sn [Statistics & Numerical Data]
- Clinical Trials, Phase III as Topic
- Clinical Trials, Phase III as Topic/sn [Statistics & Numerical Data]
- Diabetes Mellitus, Type 2/co [Complications]
- Diabetes Mellitus, Type 2/dt [Drug Therapy]
- Diabetes Mellitus, Type 2/ep [Epidemiology]
- Diabetes Mellitus, Type 2/px [Psychology]
- Humans
- Show more
- Show less
-
Collections
-
Languages